MONTELUKAST SODIUM

Generic: MONTELUKAST SODIUM

Rising Pharma HoldingsManufacturer
ORALRoute
MONTELUKAST SODIUMActive Substance
2012-08-03Original Approval

MONTELUKAST SODIUM is FDA application ANDA202468, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DYSPNOEA
8,512 reports
2
ASTHMA
8,137 reports
3
DRUG INEFFECTIVE
6,565 reports
4
FATIGUE
6,033 reports
5
HEADACHE
5,265 reports
6
COUGH
5,169 reports
7
NAUSEA
4,646 reports
8
OFF LABEL USE
4,406 reports
9
PNEUMONIA
4,339 reports
10
PAIN
4,020 reports